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Abstract 
Backgroud: A considerable number of gastrointestinal disorders (GIDs) of varied nature (inflammatory, infec-
tious, genetic and other etiology) may produce alterations in the hard and soft oral tissues. Among these are 
Crohn’s disease, ulcerative colitis, celiac and gastroesophageal reflux disease.
Material and Methods: Article search was done using the National library of medicine (PubMed) database using 
different search terms and analyzed according to their importance.
Results: A large variety of GIDs can give rise to oral lesions, including: RAS like ulceration, mucosal tags, cob-
blestoning, mucogingivitis, labial and facial swelling, pyostomatitis vegetans, disgeusia and dental abnormalities, 
among others. Although in most cases the gastrointestinal signs and symptoms highlight in the clinical picture, a 
considerable percentage of these patients are affected by oral manifestations before the onset of gastrointestinal 
symptoms.  This lesions can cause significant functional and aesthetics damages as well deteriorate the patient 
quality of life.
Conclusions: Although the frequency of oral manifestations is variable across GIDs and in most cases is non-spe-
cific, these alterations may precede the underlying disease and therefore can facilitate an opportune diagnosis.
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Introduction
It is well known that a considerable number of syste-
mic diseases can affect the oral cavity. Among these 
are the gastrointestinal disorders (GIDs), which have 
a high worldwide prevalence and a growing incidence. 
Although gastrointestinal signs and symptoms are pre-
dominant, oral manifestations may occur and even he-
rald the onset of the underlying GID. 
Material and Methods
The search of articles was done using the National library 
of medicine (PubMed) database. The following search 
terms were used: Gastrointestinal diseases, Gastrointes-
tinal pathology, Inflammatory bowel diseases, Crohn´s 
disease, Ulcerative colitis, Gardner´s syndrome, Peutz-
Jeghers syndrome, Celiac disease, Coeliac disease, Celiac 
sprue, Peptic Ulcer, Helicobacter pylori gastritis, Gastroe-
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sophageal reflux disease, Pernicious anemia, Plummer 
Vinson syndrome, Patterson-Kelly syndrome and Hiatal 
Hernia. Each of above terms were combined with the fo-
llowing words: AND oral cavity, AND oral mucosa, AND 
buccal mucosa, AND orofacial region, AND oral mani-
festation, AND mouth. The studies included were those 
articles in English that had the search words in their title, 
abstract or text. Those articles that did not have informa-
tion about the topics of the diseases treated in this review 
or with clear mistakes in their methodology were exclu-
ded. Although systematic reviews were the study design 
of predilection, case report and case series studies were 
also included because of the rarity of some diseases.
Results
As shown in table 1, many GIDs can give rise to diffe-
rent oral lesions. In this review we will focus in the most 
frequent gastrointestinal disorders.
-Inflammatory bowel diseases 
Etiology Disease Oral manifestations
Inflammatory Crohn s´ disease Mucosal tags, cobblestoning, mucogingivitis, labial and 
facial swelling, linear ulcerations, RAS like ulcerations, 
angular cheilitis (3,6,7,12).
Ulcerative colitis Pyostomatitis vegetans. Other non-specific alterations 
present in Crohn s´ disease (e.g. RAS like ulcerations, angular 
cheilitis, atrophic glossitis) (3,18).
Genetic Gardner s´ syndrome Osteomas, dental abnormalities (e.g. odontomas, impacted 
and supernumerary teeth).
Peutz Jeghers syndrome Melanotic macules and lesions secondary to anemia.
Hypersensitivity Celiac disease Enamel hypoplasias, delayed tooth eruption, bleeding 
tendency, dermatitis herpetiformis, signs and symptoms 
secondary to the anemia (e.g. glossitis, RAS like ulcerations) 
(20).
Infectious Peptic Ulcer disease Dark erythematous tongue with a slimy yellowish coating. 
Congestion and dilatation of sublingual veins (37).
Helicobacter pylori associated 
gastritis
Symptoms related to anemia (37).
Others Gastroesophageal reflux disease Dental erosions, dysgeusia, sour taste, halitosis, 
mucositis, hyperesthesia, burning mouth, RAS like 
ulcerations (32,33,35,36,38).
Pernicious anemia Atrophic glossitis, glossodynia, RAS like ulcerations (14).
Plummer Vinson syndrome Dysphagia and lesions secondary to the ferropenic anemia 
(e.g. stomatitis, RAS likes ulcerations, angular cheilitis, 
pallor of the mucosa, atrophic glossitis) (9).
Hiatal Hernia Oral manifestations related with gastroesophageal reflux 
disease and anemia (37).
Table 1: Oral manifestations of gastrointestinal disorders.
The term inflammatory bowel disease (IBD) involves 
a group of chronic inflammatory disorders of not well 
known etiology that affects different portions of the gas-
trointestinal tract, mainly the bowels (1). The two main 
forms of IBD are Crohn’s disease (CD) and Ulcerative 
Colitis (UC) (2). The signs and symptoms are related to 
the damage in the bowel, but in some cases the patient 
can exhibit extra intestinal manifestations on the oral ca-
vity, even before to the outbreak in the bowels (2-4). 
-Crohn’s disease 
Patients with Crohn´s disease develop chronic inflam-
mation and non-caseating granulomas in different parts 
of the gastrointestinal tract, especially in the distal ileum 
and colon (5). The most common signs and symptoms 
include diarrhea and abdominal pain, but some patients 
could experience extra-intestinal manifestations of the 
disease, involving eyes, joints, skin and mouth (6). 
Epidemiology
CD usually affects males in their third decade of life; 
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however, it can appear in a wide range of ages including 
young children’s (1). Its incidence varies depending on 
the age of the group studied, being higher in pediatric 
patients. Regarding to its prevalence, there are geogra-
phical differences, but it has been estimated between 
319 and 322 cases per 100,000 habitants (5).
Etiopathogenia 
The exact cause and pathogenesis of CD is still not 
known. It has been postulated that genetically predispo-
sed individuals would present an imbalance or deregula-
tion of their immune response when exposed to different 
agents, such as environmental (stress, tobacco and diet) 
and microbiological (bacterial species) agents leading to 
the pro-inflammatory environment and tissue damage 
seen in this disease (5). 
Oral manifestations 
Oral lesions in CD are more frequent in young male pa-
tients (3) and their prevalence can range from 20 to 50% 
(3,7,8). The predominant clinical presentation of the 
oral lesions includes ulcers, papules and edema, while 
the most common sites affected are lips, gingiva and the 
vestibular sulci (9). It has been reported that oral lesions 
are of help in the diagnosis of systemic Crohn’s disease 
(10). Patients with active CD have been reported to have 
a higher degree of oral lesions (7), but apparently, the 
type of oral lesion has no relationship with the disease 
activity and  type of treatment (3,7,8). Different types of 
oral lesions can coexist in the same patient, and accor-
ding to the absence or presence of granulomas formation 
in the histopathological study, these are classified into 
specific and non-specific lesions respectively (3,4). 
Specific oral lesions:
Labial swelling and fissuring: Consist in a chronic enlar-
gement of the lips with perpendicular fissures, cracks or 
crusts along the vermilion (3,7,11)
Mucosal tags: Also known as epithelial tags or folds. 
Consist in white or normal color reticular tags often pre-
sent in the vestibule and retro-molar region (3,8).  
Cobblestoning: The yugal mucosa exhibits normal color 
plaques separated by mild depressions or fissures, giving 
the appearance of cobblestones. In some circumstan-
ces, these lesions can difficult normal function, such as 
chewing (3,12).
Mucogingivitis: The gingival tissues may become hy-
perplasic and granular, not only the free gingiva but also 
the attached gingiva, and in certain cases this lesion can 
be extended up to the mucogingival margin (8).  
Linear ulcerations: These lesions are usually located in 
the buccal sulci and may be accompanied by hyperplas-
tic mucosa at their borders  (2,3,8).
Non-specific oral manifestations:
Recurrent aphtous stomatitis (RAS) like ulceration: It is 
one of the more prevalent lesions among patients with 
CD, being reported in up to 27% of all CD cases (13). 
Clinically, RAS like oral ulceration present as recurrent 
bouts of usually multiple, round or ovoid superficial ul-
cers that have circumscribed margins surrounded by an 
erythematous halo, clinically indestenguible from RAS 
(14).  RAS like ulcerations must be differentiated from 
RAS, because by definition, RAS arises in patients who 
are otherwise well, which is not the case in these pa-
tients. In contrast to the intestinal ulcers, they have no 
clinical significance (7). It is important to highlight that 
RAS like lesions are not specific of CD, hence they are 
present in several disorders (e.g. AIDS, celiac disease, 
Behcet´s syndrome, anemia) (14).
Angular cheilitis: The commissure and adjacent skin 
may have recurrent fissures and indurated erythematous 
plaques not necessarily related with candida infection. 
According to the study of Lisciandrano et al. (7), it is the 
most prevalent lesion among patients with IBD. 
Pyostomatitis vegetans: Although it is described as an 
oral manifestation in patients with CD (15), it is more 
frequent in patients with ulcerative colitis and hence will 
be described in the corresponding section.  
Other non-specific oral findings reported in literature: 
Include submandibular lymphadenopathy, sicca syndro-
me and hyposialia, dental caries, halitosis, candidiasis, 
dysphagia, odynophagia, lichen planus, dysgeusia, glos-
sitis, mucosal discoloration, periodontal involvement, 
perioral erythema with scaling and minor salivary gland 
enlargement (3, 7). 
Despite most of the oral manifestations of CD are not 
severe and their symptoms are mild or absent, some 
patients may experience facial distortion and disabling 
pain, originating emotional stress and deteriorating qua-
lity of life (9). 
Treatment 
The treatment of CD is focused in the control of the 
underlying intestinal involvement and in some circums-
tances, of its extra-intestinal manifestations (if they are 
symptomatic or are causing cosmetic issues). Treatment 
is usually performed by drug administration (steroids, 
immunosuppressive and/or biological agents), although 
some cases are managed surgically (9). Usually oral le-
sions are well managed with topical steroids, but the use 
of systemic agents might be necessary for some cases. 
-Ulcerative colitis
Ulcerative colitis (UC) is classified together with CD in 
the group of IBDs, but it has clinical and histopatholo-
gical features that differentiate it from CD. Firstly, the 
chronic inflammation of the gastrointestinal tract is limi-
ted to the mucosa of the rectum and colon, and only in 
some rare instances it can spread to upward portions of 
the digestive tube (e.g. small intestine). Secondly, within 
the inflammation there is no granuloma formation, which 
is a main feature of CD. The disease usually progresses 
with repeatedly periods of remissions and exacerbations, 
and in severe cases, can affect the entire thickness of the 
intestinal wall which can cause important bleeding. Di-
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gestive signs and symptoms of UC are chronic diarrhea, 
abdominal pain, weight loss and fatigue (16).
Epidemiology 
Ulcerative colitis shows a predilection for males and is 
twice more frequent than CD (17). Contrary to CD, UC 
is commonly diagnosed in slightly older patients with a 
mean age of 32 years (16). The occurrence of UC follows 
a bimodal pattern, with peaks in the early adulthood and 
between the sixth and seventh decade of life. Europe is 
the continent with the highest incidence, with 24.3 new 
cases per 100,000 person each year (17). 
Etiopathogenia 
Similarly to CD, it is postulated that the development of 
UC would be influenced by different factors, including 
microbiological, genetic and environmental components 
that would interact between each other triggering the di-
sease (1). 
Oral manifestations 
Pyostomatitis vegetans (PV): Is the oral counterpart of 
the Pyoderma gangrenosum and is highly associated 
with UC, and unlike the majority of the oral lesions, it 
has been reported to be a specific marker of the disea-
se activity (3, 18). PV is cataloged as a chronic muco-
cutaneous pathology that consists in the formation of 
numerous pustules (intra and sub epithelial abscesses) 
of white-yellowish content with an erythematous and 
edematous base. These lesions may break or coalesce 
giving a snail track appearance (18). The patient can 
experience fever, submandibular adenopathy and pain, 
symptoms that are highly variable and are not necessa-
rily related with the extension and size of the ulcers (3). 
In the few cases reported in the literature, the lesions 
have been found on the tongue, lips, gingiva, tonsillar 
pillars, buccal mucosa and soft and hard palate (6). As 
for the etiology, it remains obscure and researches have 
not been able to attribute a microbiological cause (18). 
Others: In some occasions, patients with UC can also 
be affected by some oral lesions more common in CD, 
such as RAS like ulcers (reported up to 13% of cases), 
glossitis, cheilitis, stomatitis, mucosal ulcers and gingi-
val inflammation (3, 7, 9). These lesions (like in CD) 
usually arise as a result of the nutritional deficiencies 
(e.g. iron, folate or B12) secondary to the intestinal in-
volvement and/or as an adverse side effect of drugs used 
to treat UC (7). 
Treatment 
The first line treatment consists in the use systemic cor-
ticosteroids, which usually helps in the remission of the 
oral manifestations. Immunosuppressive and biological 
agents are also commonly used. 
-Celiac disease
Celiac disease (CD), also known as “Coeliac sprue”, is 
an autoimmune disease in which genetically predisposed 
individuals exhibit damages in the small intestine villi as 
a consequence of an abnormal immune response sub-
sequent to the ingestion of gluten (7). The diagnosis of 
CD is made from the clinical and histological findings, 
which also allows to classify this disease into four main 
types; classical, atypical, silent and latent (19).
Etiopathogenia 
Gluten (present in most cereals) is partially degraded 
by the action of gastro-intestinal enzymes into peptides 
that passes into the intestinal corion due to an increased 
permeability of the epithelial barrier. Once in the lamina 
propia, peptides are modified by tissue transglutaminase, 
which increases their affinity for receptors on the antigen 
presenting cells (APC’s) and thus their immunogenicity 
(20). The presentation of these peptides to CD4+ lympho-
cytes triggers an adaptive immune response with the con-
sequent inflammation and tissue damage produced by the 
release of cytokines and matrix metalloproteinases (19). 
Epidemiology 
It has been estimated that CD affects approximately 1% 
of the world’s population (21), but over the last years, 
CD has experienced a large increase, affecting 1 in every 
85 to 300 people (20). Celiac disease is more common in 
European countries as well as developing regions such 
as South America, South Asia and South Africa. Despite 
being typically developed in childhood, recent studies 
reported an increase in the involvement of adults. Wo-
men are considerably more affected than men, presen-
ting a female-male ratio from 7:1 (21). 
Oral Manifestations
Numerous authors have described different oral mani-
festations associated with CD, which are particularly 
important, considering that 50% of the patients with CD 
do not exhibit digestive symptoms at the time of diag-
nosis (28). Furthermore, oral lesions would be useful in 
early detection of atypical CD, which corresponds to the 
most common form of this disease (20).
Dental enamel defects: Patients with CD show increased 
risk for enamel developmental abnormalities, specifi-
cally enamel hypoplasia (22). In the temporal dentition 
the most affected teeth are second molars, while in the 
permanent teeth the central incisors are most commonly 
affected Generally, enamel hypoplasia is distributed bi-
laterally and symmetrically in both dental arches (20, 
22). 
Atrophic glossitis and glossodynia: Even though depapi-
lation and tongue burning sensation have been described 
as oral repercussions of CD, these manifestations are 
less common compared to other oral signs and symp-
toms (20). Despite the above, an analysis of 128 cases of 
CD cataloged the tongue as the most common affected 
oral site; 29.6% of the cases presented a painful-burning 
sensation and 8.6% erythema or atrophy of the tongue 
(7). Nevertheless, these signs and symptoms are likely 
to be secondary to anemia and hematinic deficiencies, 
often seen in celiac patients, rather than be caused by the 
disease itself (23). 
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Salivary flow and saliva composition: A decrease in sali-
vary flow rates have been reported to be associated with 
the active phase of the disease, resulting in a dry mouth 
and burning sensation of the tongue (20). 
Caries: Different studies (20, 24) have described a hig-
her rate of caries in celiac patients. This higher carioge-
nic risk would be supported by the increased suscepti-
bility to caries of the hypoplastic enamel and the above 
mentioned alterations in salivary flow rates and saliva 
composition seen in CD patients.
RAS like oral ulceration: So far, there is no consensus on 
the relationship between aphthous ulcers and CD. Some 
researches (25) support the association between these 
two diseases, while others do not (26, 27). It is likely 
that the appearance of RAS like ulcers is secondary to 
anemia and hematinic deficiencies (28).
Bleeding tendency: Celiac disease has been associated 
with alterations in coagulation, which would facilitate 
the onset of bleeding in the affected patients (e.g. epis-
taxis and skin bleeding). This coagulopathy is the result 
of abnormalities in prothrombin caused by poor absorp-
tion of vitamin K (29).
Dermatitis herpetiformis: Corresponds to a dermatolo-
gical disorder strongly associated with celiac disease. 
In most of the cases the signs (mainly vesicles) and 
symptoms of itching, burning or pain affect the skin 
(e.g. buttocks, elbow), although some patients may ex-
perience lesions in the oral mucosa. The oral manifesta-
tions include erythematous-purpuric macules, erosions, 
ulcers and vesicles, which can affect the tongue, buccal 
mucosa and alveolar ridge (30). Clinically, it is difficult 
to differentiate it from other blistering diseases such as 
pemphigus or pemphigoid, so histological and immu-
nofluorescence studies are necessary when suspected.  
Treatment
The treatment of CD consists in the elimination of glu-
ten from diet (e.g. cereals, such as wheat, rye and bar-
ley) which is effective in the remission of signs and 
symptoms, including those present in the oral cavity. 
This dietary restriction also applies in cases without 
gastrointestinal symptoms, because they play a protec-
tive role against long-term complications, such as the 
development of malignancies, specially non-Hodgkin´s 
lymphoma, in both gastrointestinal and extra intestinal 
sites (31).
-Gastroesophageal reflux disease 
Gastroesophageal reflux (GER) is considered a normal 
physiological event of the human body (32). This natural 
process involves the regurgitation of gastric contents into 
the esophagus, which is then removed and neutralized 
by several protecting factors (e.g. esophageal peristalsis 
and saliva) (33). In some individuals this reflux of gastric 
and duodenal contents towards the esophagus generates 
a clinical picture called gastroesophageal reflux disease 
(GERD), characterized by the occurrence of different 
clinical signs and symptoms that are usually located in 
the esophagus (esophageal syndrome) (34) Other organs 
can also be affected, such as the pharynx, larynx, respi-
ratory system and the oral cavity. When this happens, it 
is known as extra esophageal syndrome. GERD classical 
symptoms are heartburn and sour taste, but dysphagia, 
sore throat, odynophagia, globus sensation and nausea 
are also commonly reported (32-34).
Epidemiology 
GERD is a global health problem with a high incidence 
and prevalence, and is becoming more common among 
children and adults. GERD usually manifests in the four-
th decade of life with a predilection for females (32), and 
affects up to 20% of the Western European and North 
American population (34). 
Etiopathogenia 
Different mechanical barriers and physiological mecha-
nisms, such as salivary flow rates, swallowing mecha-
nisms and esophageal peristalsis, tend to keep in balance 
the GER. The impairment on these regulatory factors 
and an increase in the flow of stomach contents into the 
esophagus and superior aero digestive tract, can lead to 
the appearance of GERD 34).   
Oral manifestations 
Dental erosion: Is one of the most common extra-esopha-
geal manifestations. Up to 44% of GERD patients pre-
sent dental erosions within the course of the disease (35, 
36). It usually affects the lingual or palatal surface of the 
anterior teeth (37). The severity can be variable, with 
most cases showing only a mild loss of enamel, while 
others can have a severe exposure of dentin (35). 
Xerostomia: It is likely that xerostomia appears as an 
adverse side effect of the medication taken for treating 
GERD, rather than being cause by GERD itself. Proton 
pump inhibitors are the first drug of choice and are likely 
to cause dry mouth sensation (37).
Halitosis: Even though the main determinants of halito-
sis or bad breath correspond to the patient’s oral condi-
tions (e.g. periodontal problems or tongue coating), an 
increased risk of halitosis has been reported in in cases 
of symptomatic GERD. This was explained by a dimi-
nished function of the lower esophageal sphincter, which 
would facilitate flow of gases and gastric contents into 
the esophagus, producing the characteristic bad smell 
(38).
Mucositis: It might appear due the contact of the acids 
or its vapors with the oral mucosa. The oral mucosa is 
observed erythematous, generally on the palate and uvu-
la, and the patient may complaint of burning sensation 
and/or pain (32). In some cases, the damage can be only 
microscopic, so no clinical signs can be seen (but the pa-
tient may still accuse some symptoms, such as burning 
sensation) (33).
Others: It has also been reported a higher incidence of 
RAS like ulceration, sour taste and burning mouth (37, 
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38). RAS like ulcerations are likely to be secondary to 
anemia or hematinic deficiencies, which are not uncom-
mon among these patients. Some patients may also ex-
perience an exaggerated sensitivity of the oral tissues 
to tactile stimuli (hyperesthesia) probably due to local 
irritation by the gastric reflux. 
Treatment
The use of proton pump inhibitors is the treatment of 
choice. It provides the advantage of being non-invasive, 
cost effective and can serve as a diagnostic criterion for 
GERD. In some cases, drug therapy is not sufficient to 
control the symptoms, so an anti-reflux surgery can be 
considered (32).
Conclusions
Although the frequency of oral manifestations is variable 
across GIDs and in most cases is non-specific (such as 
RAS like ulceration, stomatitis, burning sensation, etc.), 
these alterations may precede the underlying disease and 
therefore can facilitate an opportune diagnosis.
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